... 24. In
preparation for this
Regulation, the
Commission has
launched REACH
Implementation Projects (RIPs), involving
relevant experts from
stakeholder groups. Some of those
projects aim at developing
draft guidelines and tools which should
help the
Commission, the
Agency,
Member States,
manufacturers,
importers and
downstream users of
substances to fulfil, in concrete
terms, their
obligations under this
Regulation. This
work should enable the
Commission and the
Agency to make available appropriate
technical guidance, in
due time, with
regard to the deadlines
introduced by this
Regulation. ...
... Any
manufacturer,
importer, or where
relevant downstream user, may, whilst retaining
full responsibility for complying with his
obligations under this
Regulation, appoint a
third party representative for all
proceedings under
Article 11,
Article 19, Title III and
Article 53 involving
discussions with other
manufacturers,
importers, or where
relevant downstream users. In these
cases, the
identity of a
manufacturer or
importer or
downstream user who has appointed a
representative shall not normally be disclosed by the
Agency to other
manufacturers,
importers, or, where
relevant,
downstream users. ...
... Any
manufacturer,
importer, or where
relevant downstream user, may, whilst retaining
full responsibility for complying with his
obligations under this
Regulation, appoint a
third party representative for all
proceedings under
Article 11,
Article 19, Title III and
Article 53 involving
discussions with other
manufacturers,
importers, or where
relevant downstream users. In these
cases, the
identity of a
manufacturer or
importer or
downstream user who has appointed a
representative shall not normally be disclosed by the
Agency to other
manufacturers,
importers, or, where
relevant,
downstream users. ...
ARTICLE-7: Registration and notification of substances in articles [
go to this ARTICLE]
ARTICLE-8: Only representative of a non-Community manufacturer [
go to this ARTICLE]
ARTICLE-11: Joint submission of data by multiple registrants [
go to this ARTICLE]
ARTICLE-19: Joint submission of data on isolated intermediates by multiple registrants [
go to this ARTICLE]
ARTICLE-28: Duty to pre-register for phase-in substances [
go to this ARTICLE]
ARTICLE-55: Aim of authorisation and considerations for substitution [
go to this ARTICLE]
ARTICLE-111: Formats and software for submission of information to the Agency [
go to this ARTICLE]
ARTICLE-113: Obligation to notify the Agency [
go to this ARTICLE]
ARTICLE-136: Transitional measures regarding existing substances [
go to this ARTICLE]